Ribociclib CAS NO.1256963-02-6

Ribociclib is a CDK4/6 inhibitor. It has been recently approved by FDA (brand name: Kisqali®) to be combined with an aromatase inhibitor for initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer. It inhibits the growth of tumor cells by arresting the cells at the G1 checkpoint, which prevents the tumor cells from proliferating. 

Hangzhou Huarong Pharm Co., Ltd. established since 2009 , has been always focusing on supplying products and services to our clients in the field of small molecule drug. 

Huarong Pharm has built platforms for the research, development and manufacturing of Building Blocks, Reference Compounds & Impurities, Natural products, APIs & Intermediates, Antibody-drug Conjugates (ADCs) and others. To maintain a high innovation efficiency, the company has continuously increased the investment on R&D facilities and state-of-the-art equipment in the past several years, including the establishment of kilogram GMP conditions plants and R&D centers.

Huarong Pharm adheres to our vision, our mission, and our value, keeping abreast of the current trend and state-of-the-art science and technologies of the global biopharmaceutical industry to serve our clients to the utmost satisfaction. Our existing advantages have led to our in-depth services for the R&D of small molecule drug discovery.

At present, Huarong Pharm has successfully delivered innovative R&D products and services to more than 3,000 partners across the world. Our goal is to become a world-class leading company to support life science innovation and manufacturing.

1.Huarong Pharm possesses a high-level R&D team with more than ten years of rich experience. They can quickly design and optimize synthetic routes, and provide customized R&D services for products with the size ranging from milligram to kilogram. We provide a technology platform and advanced technical reserves in the field of customized synthesis, and professional support from quality control and customer service teams. We are widely recognized by customers ranging from pharmaceutical companies, research institutes and universities, etc. Seamless customer interface, efficient communication and fulfilling mission are our consistent goals.

Customized synthesis of building blocks

Customized synthesis of reference compounds and compound libraries

Customized synthesis of APIs and intermediates

Customized synthesis of impurity controls

Customized synthesis of specialty chemicals

2. Huarong Pharm has excellent technical research and development strength and has been committed to the process of innovation, research and development for many years. With profound professional accumulation in the pharmaceutical industry, as well as advanced technology research and development systems and standardized service management systems, we can provide customers with one-stop service from pre-clinical to commercial. Thanks to the support from our professional synthesis, QC, QA and registration teams, we can make an immediate response and provide efficient service to meet our customers' different demands on process research and development.

3.Our R&D team follows the concept of QbD , We plan from a design perspective and use our own or outsourced production resources for various specifications and systems to provide customized and commissioned production of APIs or intermediates. Especially in the field of high-potency API research, the company is equipped with a series of advanced devices and instruments. Currently, we have completed the development of several series of highly active API or intermediate products. Our R&D team has rich experience. Moreover, both the GMP-like laboratory in Hangzhou R&D Center and the GMP laboratory in Yongan R&D Center can effectively support the development, production and registration of high-potency drug intermediates and API products to meet R&D and production needs of different partners.

Commissioned production of marketed APIs or intermediates

Commissioned development and production of innovative APIs or intermediates

Commissioned development and production of high-potency APIs or intermediates

4.The company has a professional analysis and quality research team and an experienced registration application service team, which provides comprehensive services ranging from pre-clinical to commercialization, from new drugs to generic drugs. Our teams use a standardized management system to ensure the authenticity and professionalism of the dossiers and assist the drug regulatory authorities in the inspection. We are highly efficient in providing drug registration application services to meet regulatory requirements for domestic and foreign customers. Currently, the company has completed many successful cases in the field of registration application services.